CAZypedia needs your help!
We have many unassigned pages in need of Authors and Responsible Curators. See a page that's out-of-date and just needs a touch-up? - You are also welcome to become a CAZypedian. Here's how.
Scientists at all career stages, including students, are welcome to contribute.
Learn more about CAZypedia's misson here and in this article.
Totally new to the CAZy classification? Read this first.
Difference between revisions of "Glycosyltransferase Family 38"
Harry Brumer (talk | contribs) m (adjusted multiple consecutive citations) |
|||
Line 33: | Line 33: | ||
== Substrate specificities == | == Substrate specificities == | ||
− | Members of GT-38 are the bacterial polysialyltransferases (polySTs), which catalyze the addition of sialic acids from the activated sugar donor, CMP-sialic acid (CMP-Neu5Ac), to the nonreducing end of the growing polySia chain <cite> | + | Members of GT-38 are the bacterial polysialyltransferases (polySTs), which catalyze the addition of sialic acids from the activated sugar donor, CMP-sialic acid (CMP-Neu5Ac), to the nonreducing end of the growing polySia chain <cite>Cho1994</cite>. These enzymes build the polymer as a capsular polysaccharide on a specialized poly-β-KDO modified lyso-phosphatidyl glycerol anchor in the membrane of Gram negative bacteria <cite>Willis2013</cite>. Bacterial polySia capsules exist in three different flavours: ''Escherichia coli'' K1, ''Neisseria meningitidis'' serotype B, ''Moraxella nonliquefaciens'', and ''Mannheimia haemolytica'' A2 synthesize α-2,8-linked polySia whereas ''N. meningitidis'' serotype C produces a α-2,9-linked polymer and ''E. coli'' K92 produces polymers with alternating α-2,8 and α-2,9 linkages <cite>Jennings1977 PuentePolledo Devi1991 Glode1977</cite>. ''In vitro'' enzyme reactions have shown that the members of GT-38 require two sialic acids for elongation <cite>Willis2008 Peterson2011 Lindhout2013</cite>, presumably as this mimics the ''in vivo'' lipid primer. The enzymes have been used in applications to modify therapeutic proteins and prepare synthetic vaccines <cite>Lindhout2011 McCarthy2013</cite>, where un-natural acceptors like protein N-glycans have been used. |
== Kinetics and Mechanism == | == Kinetics and Mechanism == | ||
− | Sialic acid transfer occurs with inversion of configuration (from the β-linked CMP-Neu5Ac donor to the | + | Sialic acid transfer occurs with inversion of configuration (from the β-linked CMP-Neu5Ac donor to the α-2,8-linked polySia), and polyST has been proposed to follow a SN2-like direct displacement mechanism. While H291 could act as a catalytic acid to stabilize the nucleotide phosphate-leaving group. |
− | α-2,8-linked polySia), and polyST has been proposed to follow a SN2-like direct displacement mechanism. While | ||
− | H291 could act as a catalytic acid to stabilize the nucleotide phosphate-leaving group. | ||
== Catalytic Residues == | == Catalytic Residues == | ||
Line 45: | Line 43: | ||
== Three-dimensional structures == | == Three-dimensional structures == | ||
− | + | <gallery widths=320px heights=240px perrow=2 caption="PDB ID 5WC6 from GT38 (click images for large versions)"> | |
File:GT38 3.png | File:GT38 3.png | ||
File:GT38 4.png | File:GT38 4.png | ||
Line 57: | Line 55: | ||
== References == | == References == | ||
− | + | <biblio> | |
− | |||
# Cho1994 pmid=7972078 | # Cho1994 pmid=7972078 | ||
# Willis2013 pmid=23610430 | # Willis2013 pmid=23610430 | ||
− | |||
# Jennings1977 pmid=408435 | # Jennings1977 pmid=408435 | ||
# PuentePolledo pmid=10052589 | # PuentePolledo pmid=10052589 | ||
# Devi1991 pmid=1898915 | # Devi1991 pmid=1898915 | ||
# Glode1977 pmid=64575 | # Glode1977 pmid=64575 | ||
− | |||
# Lindhout2013 pmid=23922842 | # Lindhout2013 pmid=23922842 | ||
# Peterson2011 pmid=21278299 | # Peterson2011 pmid=21278299 | ||
− | |||
# Lindhout2011 pmid=21502532 | # Lindhout2011 pmid=21502532 | ||
# McCarthy2013 pmid=23949787 | # McCarthy2013 pmid=23949787 | ||
− | |||
# Willis2008 pmid=18000029 | # Willis2008 pmid=18000029 | ||
− | |||
# Lizak2017 pmid=28724897 | # Lizak2017 pmid=28724897 | ||
− | |||
</biblio> | </biblio> | ||
[[Category:Glycosyltransferase Families|GT038]] | [[Category:Glycosyltransferase Families|GT038]] |
Revision as of 15:21, 27 May 2020
This page is currently under construction. This means that the Responsible Curator has deemed that the page's content is not quite up to CAZypedia's standards for full public consumption. All information should be considered to be under revision and may be subject to major changes.
- Author: ^^^Warren Wakarchuk^^^
- Responsible Curator: ^^^Warren Wakarchuk^^^
Glycosyltransferase Family GT38 | |
Clan | GT-B |
Mechanisn | inverting |
Active site residues | known |
CAZy DB link | |
https://www.cazy.org/GT38.html |
Substrate specificities
Members of GT-38 are the bacterial polysialyltransferases (polySTs), which catalyze the addition of sialic acids from the activated sugar donor, CMP-sialic acid (CMP-Neu5Ac), to the nonreducing end of the growing polySia chain [1]. These enzymes build the polymer as a capsular polysaccharide on a specialized poly-β-KDO modified lyso-phosphatidyl glycerol anchor in the membrane of Gram negative bacteria [2]. Bacterial polySia capsules exist in three different flavours: Escherichia coli K1, Neisseria meningitidis serotype B, Moraxella nonliquefaciens, and Mannheimia haemolytica A2 synthesize α-2,8-linked polySia whereas N. meningitidis serotype C produces a α-2,9-linked polymer and E. coli K92 produces polymers with alternating α-2,8 and α-2,9 linkages [3, 4, 5, 6]. In vitro enzyme reactions have shown that the members of GT-38 require two sialic acids for elongation [7, 8, 9], presumably as this mimics the in vivo lipid primer. The enzymes have been used in applications to modify therapeutic proteins and prepare synthetic vaccines [10, 11], where un-natural acceptors like protein N-glycans have been used.
Kinetics and Mechanism
Sialic acid transfer occurs with inversion of configuration (from the β-linked CMP-Neu5Ac donor to the α-2,8-linked polySia), and polyST has been proposed to follow a SN2-like direct displacement mechanism. While H291 could act as a catalytic acid to stabilize the nucleotide phosphate-leaving group.
Catalytic Residues
Residues involved in catalysis have been proposed from site-directed mutagensis and the X-ray crystal structure from the M. hemolytica serotype A2 enzyme [12]. The catalytic base E153 abstracts a proton from the C8′ hydroxyl group of the sialic acid acceptor concerted with the nucleophilic attack on the anomeric C2′ carbon of the CMP-sialic acid donor substrate, thereby generating an α-2,8 glycosidic linkage. The resulting negatively charged CMP leaving group is stabilized by H291 assisted by S339 and T340.
Three-dimensional structures
Family Firsts
- First general acid/base residue identification
- E153, H291
- First 3-D structure
- PDB 5WC6
References
- Cho JW and Troy FA 2nd. (1994). Polysialic acid engineering: synthesis of polysialylated neoglycosphingolipids by using the polysialyltransferase from neuroinvasive Escherichia coli K1. Proc Natl Acad Sci U S A. 1994;91(24):11427-31. DOI:10.1073/pnas.91.24.11427 |
- Willis LM, Stupak J, Richards MR, Lowary TL, Li J, and Whitfield C. (2013). Conserved glycolipid termini in capsular polysaccharides synthesized by ATP-binding cassette transporter-dependent pathways in Gram-negative pathogens. Proc Natl Acad Sci U S A. 2013;110(19):7868-73. DOI:10.1073/pnas.1222317110 |
- Jennings HJ, Bhattacharjee AK, Bundle DR, Kenny CP, Martin A, and Smith IC. (1977). Strucutres of the capsular polysaccharides of Neisseria meningitidis as determined by 13C-nuclear magnetic resonance spectroscopy. J Infect Dis. 1977;136 Suppl:S78-83. DOI:10.1093/infdis/136.supplement.s78 |
- Puente-Polledo L, Reglero A, González-Clemente C, Rodríguez-Aparicio LB, and Ferrero MA. (1998). Biochemical conditions for the production of polysialic acid by Pasteurella haemolytica A2. Glycoconj J. 1998;15(9):855-61. DOI:10.1023/a:1006902931032 |
- Devi SJ, Schneerson R, Egan W, Vann WF, Robbins JB, and Shiloach J. (1991). Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated). Infect Immun. 1991;59(2):732-6. DOI:10.1128/iai.59.2.732-736.1991 |
- Glode MP, Robbins JB, Liu TY, Gotschlich EC, Orskov I, and Orskov F. (1977). Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis. 1977;135(1):94-104. DOI:10.1093/infdis/135.1.94 |
- Willis LM, Gilbert M, Karwaski MF, Blanchard MC, and Wakarchuk WW. (2008). Characterization of the alpha-2,8-polysialyltransferase from Neisseria meningitidis with synthetic acceptors, and the development of a self-priming polysialyltransferase fusion enzyme. Glycobiology. 2008;18(2):177-86. DOI:10.1093/glycob/cwm126 |
- Peterson DC, Arakere G, Vionnet J, McCarthy PC, and Vann WF. (2011). Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase. J Bacteriol. 2011;193(7):1576-82. DOI:10.1128/JB.00924-10 |
- Lindhout T, Bainbridge CR, Costain WJ, Gilbert M, and Wakarchuk WW. (2013). Biochemical characterization of a polysialyltransferase from Mannheimia haemolytica A2 and comparison to other bacterial polysialyltransferases. PLoS One. 2013;8(7):e69888. DOI:10.1371/journal.pone.0069888 |
- Lindhout T, Iqbal U, Willis LM, Reid AN, Li J, Liu X, Moreno M, and Wakarchuk WW. (2011). Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes. Proc Natl Acad Sci U S A. 2011;108(18):7397-402. DOI:10.1073/pnas.1019266108 |
- McCarthy PC, Saksena R, Peterson DC, Lee CH, An Y, Cipollo JF, and Vann WF. (2013). Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates. Glycoconj J. 2013;30(9):857-70. DOI:10.1007/s10719-013-9490-x |
- Lizak C, Worrall LJ, Baumann L, Pfleiderer MM, Volkers G, Sun T, Sim L, Wakarchuk W, Withers SG, and Strynadka NCJ. (2017). X-ray crystallographic structure of a bacterial polysialyltransferase provides insight into the biosynthesis of capsular polysialic acid. Sci Rep. 2017;7(1):5842. DOI:10.1038/s41598-017-05627-z |